|
CCNJ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.212200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.288600E-01 |
| Normal-vs-Stage2 |
5.265400E-01 |
| Normal-vs-Stage3 |
3.474600E-01 |
| Normal-vs-Stage4 |
5.772600E-01 |
| Stage1-vs-Stage2 |
8.739000E-01 |
| Stage1-vs-Stage3 |
5.620200E-02 |
| Stage1-vs-Stage4 |
2.676400E-01 |
| Stage2-vs-Stage3 |
2.416400E-01 |
| Stage2-vs-Stage4 |
3.552800E-01 |
| Stage3-vs-Stage4 |
9.447000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.162200E-01 |
| Normal-vs-AfricanAmerican |
2.071200E-01 |
| Normal-vs-Asian |
4.593800E-01 |
| Caucasian-vs-AfricanAmerican |
1.635970E-01 |
| Caucasian-vs-Asian |
3.233400E-01 |
| AfricanAmerican-vs-Asian |
3.985800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.739600E-01 |
| Normal-vs-Female |
5.558000E-01 |
| Male-vs-Female |
3.975000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.307200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.462800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.189600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.113450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.068010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.202620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.060100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.562200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.756630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.598800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.06609999997553E-06 |
| Classical-VS-Follicular |
7.162300E-02 |
| Classical-VS-Other |
5.982000E-01 |
| Classical-VS-Normal |
6.825800E-01 |
| Tall-VS-Follicular |
2.00999999999674E-06 |
| Tall-VS-Other |
2.062400E-01 |
| Tall-VS-Normal |
2.957900E-04 |
| Follicular-VS-Other |
8.789400E-01 |
| Follicular-VS-Normal |
5.838500E-02 |
| Other-VS-Normal |
5.589000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.854000E-01 |
| Normal-vs-N1 |
2.713800E-01 |
| N0-vs-N1 |
2.548600E-01 |
|
|
